Stock Ratings / Health Care / CCM / financials

DCGO (39) PIII (24) EUDA (39) ALPS (52) ⌘ Pro Terminal →

Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Q: How profitable is Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM)?

In FY 2025 (10-K), CCM converted $65.0M of revenue into a 5.7% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

$3.59 +0.56% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $3.59

Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) carries a Roarable Rating of E (Strong Sell) with 22/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $15.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CCM Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CCM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (NYSE: CCM) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 22/100 at a spot price of $3.59 (+0.56% 1D, market cap $15.5M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 5/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, CCM ranks #963 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CCM compare to DCGO and PIII in the Health Care sector?

▼

Within the Health Care sector (Medical/Nursing Services), CCM carries a Roarable E (22/100 RQD), trailing P/E of N/A, gross margin of 5.7%, and ROIC of -35.0%. By comparison, DCGO (DocGo Inc.) holds a D- grade (39/100 RQD, P/E N/A, ROIC -35.0%, cap $24.4M) and PIII (P3 Health Partners Inc. (Class A)) posts a E grade (24/100 RQD, P/E N/A, ROIC -35.0%, cap $29.3M). Among the 5-stock peer group, CCM leads on earnings multiple (N/A) while CCM leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CCM?

▼

Per CCM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001472072), Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) generated $65.0M in revenue (+26.6% YoY), -$13.3M in net income, and -$36.9M in free cash flow against $936.3M in total assets and $352.6M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $3.59 (-0.09%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (22/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-11.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-16.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CCM)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (22/100 Composite)

🔍 WHY CCM SCORES 22/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+7/20 pts (32% of score)

FRED Regime × Technicals: 20% of 52W Range • RSI-14 at 47.6 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+5/20 pts (23% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$3.69+11.9% Next Q

Q2 (-2Q)

Grade E$4.13-15.5% Next Q

Q3 (-1Q)

Grade E$3.49+2.9% Next Q

Current

Grade E$3.59-11.4% Hist 90D α

Trajectory: E (30) → E (22)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CCM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CCM currently carries a cautious 22/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.85) and Max Pain ($3.77) forces dealer call-delta covering toward $7.14.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CCM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CCM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 22%NO 78%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How CCM Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $73.3M

FY24

Rev $51.3M

FY25

Rev $65.0M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$65.0M	5.7%	-57.6%	-$13.3M	-$36.9M	-45%
FY 2024	$51.3M	-21.1%	-80%	-$42.2M	-$75.1M	-45%
FY 2023	$73.3M	8%	-80%	-$41.9M	-$38.9M	-35%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CCM)

✓Walkthrough of CCM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CCM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -26.73%▼ DESCENDING CHANNEL

2026-11-03O $3.66H $3.66L $3.57C $3.59VOL 5.7K

RES: $5.17SUP: $2.36SMA50: $3.85SMA200: $4.21

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CCM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CCM Butterfly Map → + Track CCM →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +26.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CCM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CCM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CCM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CCM)

Health Care Rank #963 of 1015 ⚔️ DCGO vs CCM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CCM vs. DCGO, PIII, EUDA, ALPS)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) ranks #963 by composite RQD confidence (22/100, grade E) and #852 by equity capitalization ($15.5M). Within this direct 5-issuer industry benchmark cohort, CCM leads on earnings valuation at N/A trailing P/E, while CCM leads on capital efficiency and profitability with -35.0% ROIC and 5.7% gross margin. ALPS currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with CCM at 22/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CCM ACTIVE Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A)	E	22/100	—	5.7%	-35.0%	+0.56%	$15.5M	Benchmark Subject
DCGO DocGo Inc.	D-	39/100	—	—	-35.0%	-13.32%	$24.4M	/dcgo-vs-ccm →
PIII P3 Health Partners Inc. (Class A)	E	24/100	—	—	-35.0%	-0.75%	$29.3M	/piii-vs-ccm →
EUDA EUDA Health Holdings Limited	D-	39/100	—	43.9%	-35.0%	-12.03%	$53.0M	/euda-vs-ccm →
ALPS ALPS Group Inc Ordinary Share	D+	52/100	—	—	—	-0.21%	$54.1M	/alps-vs-ccm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001472072 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) reported GAAP revenue of $65.0M (+26.6% vs. FY2024 revenue of $51.3M , and -11.4% cumulative change since FY2023) , GAAP net income of -$13.3M, operating cash flow of -$28.9M, and free cash flow of -$36.9M (+50.9% YoY). On the balance sheet, CCM closed FY2025 with $936.3M in total assets against $352.6M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$65.0M	-$13.3M	-$28.9M	-$36.9M	$936.3M	$352.6M
FY2024 (FY)	2024-12-31	$51.3M	-$42.2M	-$54.5M	-$75.1M	$921.5M	$369.0M
FY2023 (FY)	2023-12-31	$73.3M	-$41.9M	-$38.9M	-$38.9M	—	—

3. CCM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CCM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CCM compare to DCGO and PIII in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for CCM?

Where is CCM trading relative to its 50-day, 200-day, and 52-week technical levels?

CCM last traded at $3.59 (+0.56% on volume of 4,042 shares), positioning the stock -6.75% below its 50-day simple moving average ($3.85) and -14.73% below its 200-day simple moving average ($4.21). Across its 52-week range of $2.79 to $6.80, CCM sits at the 20.0% percentile with a 14-day RSI of 47.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.14 to $4.04).

Direct Sub-Reports: CCM RQD Cockpit CCM 12M Forecast CCM Earnings & Move CCM Dividends & DRIP CCM Insiders & 13F CCM Whale Options CCM Profit Sankey CCM News & Why

ROARABLE RATING BRIEF • RQD 22/100 (E) ✓ SEC XBRL & RQD VERIFIED

CCM — Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) earns a live Roarable RQD composite score of 22/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $3.59 (+0.56% 1D, market capitalization $15.5M).

Fundamental Cash Engine (3/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 5.7%, operating margin of -57.6%, and free cash flow yield of —.
Whale 13F & Options Flow (5/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (7/20) + Forensic Balance Sheet (5/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Concord Medical Services Holdings Limited is a NYSE-listed issuer classified under the Health Care sector and the Medical/Nursing Services industry.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) reported $65.0M in annual revenue (up from $51.3M in FY2024, +26.6% YoY) and -$13.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($73.3M revenue, -$41.9M net income) through FY2025, CCM scaled operating cash flow to -$28.9M and free cash flow to -$36.9M, backed by $936.3M in total assets against $352.6M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 22/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 5/20. With Fundamental Cash Engine at 3/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $2.79 – $6.80 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -57.6% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medical/Nursing Services (Health Care), CCM carries a macro regime beta of 1.00 and gross margin of 5.7%.

Key Question #1: Can CCM sustain or expand its -57.6% operating margin and -35.0% ROIC against Medical/Nursing Services peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $65.0M and free cash flow of -$36.9M, how will capital allocation balance growth reinvestment against $352.6M in total debt?
Key Question #3: How sensitive is CCM's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

CCM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Concord Medical Services Holdings Limited (Each represents thirty (30) ) (Class A) (CCM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CCM Debate Forum (3) ↓

🟡 MARKET WIRE Benzinga • 14d ago

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 42.9% to $3.83 during Tuesday's regular session. Myriad Genetics (NASDAQ:MYGN) shares moved upwards by 36.85% to $5.76. The company's market cap stands at

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 178d ago

Asian Equities Traded in the US as American Depositary Receipts Edge Higher Friday

Asian equities traded in the US as American depositary receipts were edging higher Friday morning, r

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 188d ago

Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it file

Read Full Source ↗

🟡 MARKET WIRE University of Cincinnati • 21d ago

CCM faculty take the spotlight in upcoming chamber music concerts

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNTWZzdGQ4aUo4QmhiTVJ1enV4c0ZESHBxN3BoekxZU0psVU5rMlhtM2Z4bXk4Z2hVZXpTRmdpWkNGTDdlaDFWd3MzcXM2ZmRtRVZTUFBNblVqenBDQ0JtT3VTOG9OZ0xWS1EyelY3Y3lBbDJVbF9jTlI0SUd

Read Full Source ↗

🔴 RISK WATCH HousingWire • 29d ago

TWO fires back at UWM’s lawsuit, demands refund of $25M fee

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9EWmlRNTR1SXA2RGlSZzN0dmJUQlFkSFNTRVZlc0xzckFVdEVzeHduQ1IwSklkWnBRSllZSURsTHZCN3FvZUI0cHFUQW5JWFBkcDdtZkJZUmROTXYtTlE1VFdZcTZremU1NWJQQ2tPUDhWemM?oc=5" targe

Read Full Source ↗

🟡 MARKET WIRE TradingView • 8d ago

Crescent Cotton Mills Limited Estimates – PSX:CCM

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBWUTk2bW1CbGFUb0U3dmoxVzdvNUV3UlZNMUg2WW92cWk3d2lCVjVLaWVSNXY2TTJmM1FXQUdfSWEtWFpiTlhXMW9TS0xreTNSS3EyS1daMWtJR29STXRCZTBRcmM4SWx3TENCc1hLWjNOQ3c?oc=5" targe

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 27d ago

Four Analyst Firm Reports Name Elixir a CCM Leader, and Only Elixir Earned Capability Leader in the New AxisCube TriAxis Matrix

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPZjFWelIwZWhfUEg0NkpvSHVveTdVWE5POHJPUG9XS2hyWjIwNGRrb0VOMVpua0M1X3FUMnVheG5JdkR0X01neUJ0UkhpSlQ5Y3oxdU5JQkItYzhVd1VuaFRLUmFMVDJQYjZLMkNkLXN5SmpVeUlyUFRKMC1

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 14d ago

12 Health Care Stocks Moving In Tuesday's Intraday Session - SCWorx (NASDAQ:WORX), Myriad Genetics (NASDA

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOWS1nSlVmTDd6LXdrYnNGdFU4ZXg4aW5pYTJGZFlVUVZ3MkttTDNiNmFMN0tuQVZ3ckNkbk5iUjRKTDg0STc4MmJzMG1UaWdEN1gxUzF6aWJCaE5JcUJtQndlaFV1b1JnemtndlNsYkVOZ2ZJQ3pqTUN6Z0Q

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CCM Bull vs. Bear Conversation Board — What's Your Call at $3.59?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CCM 🐻 33% BEARISH CONVICTION

QU QuantViper RQD DEBATE OPENER • Systematic Momentum Desk 🐂 BULLISH 🎯 Target: $4.43 (+24.1%)

📌 Pinned Debate

Revenue recovered to $65.0M in FY 2025 after falling to $51.3M in FY 2024, and the stock trades near its 52-week low of $2.79 at a $15.

Here is why I am bullish on CCM here at $3.57: Revenue recovered to $65.0M in FY 2025 after falling to $51.3M in FY 2024, and the stock trades near its 52-week low of $2.79 at a $15.9M market capitalization.. Compare CCM's -57.6% operating margin and -35.0% ROIC against the rest of Medical/Nursing Services. As long as cash conversion holds up, dips toward $3.39 are getting bought.

ArenaChamp_24 🐂 BULL

@MultipleCompression Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Medical/Nursing Services. If gross margin (5.7%) holds, EPS grows into the multiple faster than bears think.

MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH 🎯 Target: $3.03 (-15.1%)

Spot @ $3.57

With an Altman Z-Score of 0.2, a Piotroski F-Score of 2 of 9, ROIC of -35%, and $352.6M in FY 2025 debt against $42.6M in cash, the bal

Sitting on the sidelines or leaning short CCM above $3.57. With an Altman Z-Score of 0.2, a Piotroski F-Score of 2 of 9, ROIC of -35%, and $352.6M in FY 2025 debt against $42.6M in cash, the balance sheet shows acute forensic distress.. Until Fundamental Cash Engine (2/20) and FCF yield (0.0%) inflect higher, upside is capped near $6.80.